[go: up one dir, main page]

AR026621A1 - Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion - Google Patents

Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion

Info

Publication number
AR026621A1
AR026621A1 ARP000106240A ARP000106240A AR026621A1 AR 026621 A1 AR026621 A1 AR 026621A1 AR P000106240 A ARP000106240 A AR P000106240A AR P000106240 A ARP000106240 A AR P000106240A AR 026621 A1 AR026621 A1 AR 026621A1
Authority
AR
Argentina
Prior art keywords
preparation
transdermal therapeutic
procedure
improved stability
tts
Prior art date
Application number
ARP000106240A
Other languages
English (en)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026621(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10054713A external-priority patent/DE10054713C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR026621A1 publication Critical patent/AR026621A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente se refiere a un sistema terapéutico transdermal (TTS), en el cual se reduce la formacion de productos de descomposicion por oxidacion de por lomenos una substancia activa contenida en este sistema y oxidable por medio de hidroperoxidos du rante el almacenamiento de dicho TTS, que está caracterizadoporque la suma de los índices de peroxido (POZ), que poseen en cada caso las proporciones indicadas para el TTS por las indicaciones de preparacion de la o delas substancias activas, es de 2 0 como máximo. La invencion se refiere además a un procedimiento para la preparacion de dicho sistema terapéutico transdermal.
ARP000106240A 1999-11-29 2000-11-27 Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion AR026621A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19957401 1999-11-29
DE10054713A DE10054713C2 (de) 1999-11-29 2000-11-04 Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
AR026621A1 true AR026621A1 (es) 2003-02-19

Family

ID=26007565

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106240A AR026621A1 (es) 1999-11-29 2000-11-27 Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion

Country Status (21)

Country Link
US (1) US6699498B1 (es)
EP (1) EP1233763B1 (es)
JP (1) JP5753645B2 (es)
CN (1) CN1195506C (es)
AR (1) AR026621A1 (es)
AT (1) ATE245972T1 (es)
AU (1) AU779523B2 (es)
BR (1) BRPI0015939B8 (es)
CA (1) CA2396686C (es)
CZ (1) CZ295031B6 (es)
DK (1) DK1233763T3 (es)
ES (1) ES2204732T3 (es)
HU (1) HU228822B1 (es)
IL (1) IL149812A0 (es)
MX (1) MXPA02005292A (es)
NZ (1) NZ519069A (es)
PL (1) PL198323B1 (es)
PT (1) PT1233763E (es)
RU (1) RU2266735C2 (es)
TW (1) TWI272108B (es)
WO (1) WO2001039753A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US20060216336A1 (en) * 2002-05-07 2006-09-28 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
DE102017104026A1 (de) 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
WO2020250840A1 (ja) * 2019-06-14 2020-12-17 久光製薬株式会社 ロチゴチン含有貼付剤

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103117A (en) * 1980-01-19 1981-08-18 Nitto Electric Ind Co Ltd Stabilized plaster containing drug
JPS60199832A (ja) * 1984-03-22 1985-10-09 Nitto Electric Ind Co Ltd 抗酸化性外用製剤
FR2619388A1 (fr) 1987-08-14 1989-02-17 Rhone Poulenc Chimie Article stratifie souple pour adhesif de transfert
JPH01249885A (ja) * 1988-03-30 1989-10-05 Narisu Keshohin:Kk 脂質の酸化防止剤
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JP2788754B2 (ja) * 1989-05-12 1998-08-20 日東電工株式会社 シート状経皮吸収デバイス
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3723229B2 (ja) * 1991-03-12 2005-12-07 武田薬品工業株式会社 外用貼付剤
JP3034077B2 (ja) * 1991-04-19 2000-04-17 久光製薬株式会社 メラニン抑制貼付剤
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
JPH05306227A (ja) * 1992-04-27 1993-11-19 Lion Corp 徐放性口腔内疾患治療剤
JPH0624969A (ja) * 1992-07-09 1994-02-01 Teikoku Seiyaku Co Ltd ケトプロフェン含有外用貼付剤
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
IL109539A0 (en) 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
JP3157082B2 (ja) * 1994-09-22 2001-04-16 昭和薬品化工株式会社 医療用パック型製剤用基剤および医療用パック型製剤
JP3117619B2 (ja) * 1995-06-07 2000-12-18 花王株式会社 （メタ）アクリル酸系（共）重合体の製造方法
JP3361674B2 (ja) * 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
FR2744368B1 (fr) * 1996-02-02 1998-04-24 Fabre Pierre Dermo Cosmetique Composition dermocosmetique contenant du retinal
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
PL355606A1 (en) 2004-05-04
CZ20021867A3 (cs) 2002-11-13
MXPA02005292A (es) 2002-12-11
US6699498B1 (en) 2004-03-02
CA2396686C (en) 2008-07-08
NZ519069A (en) 2004-06-25
PL198323B1 (pl) 2008-06-30
AU779523B2 (en) 2005-01-27
BR0015939B1 (pt) 2013-10-08
PT1233763E (pt) 2003-11-28
CN1402633A (zh) 2003-03-12
CA2396686A1 (en) 2001-06-07
AU2162301A (en) 2001-06-12
IL149812A0 (en) 2002-11-10
JP2003515554A (ja) 2003-05-07
EP1233763B1 (de) 2003-07-30
WO2001039753A1 (de) 2001-06-07
CZ295031B6 (cs) 2005-05-18
JP5753645B2 (ja) 2015-07-22
HUP0203318A3 (en) 2004-06-28
RU2266735C2 (ru) 2005-12-27
ES2204732T3 (es) 2004-05-01
ATE245972T1 (de) 2003-08-15
RU2002118325A (ru) 2004-02-20
HUP0203318A2 (hu) 2003-02-28
EP1233763A1 (de) 2002-08-28
DK1233763T3 (da) 2003-10-20
BRPI0015939B8 (pt) 2021-05-25
BR0015939A (pt) 2002-08-20
CN1195506C (zh) 2005-04-06
TWI272108B (en) 2007-02-01
HU228822B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
AR026621A1 (es) Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion
ATE541587T1 (de) Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen
CY1108070T1 (el) Παραγωγα κινολινονης, ως αναστολεις κινασης τυροσινης
ATE416687T1 (de) Vorrichtung zur endovaskulären behandlung von aneurysmen
AR032293A1 (es) Estuche farmaceutico
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
ES2039640T3 (es) Un metodo de tratamiento de la superficie de una resina absorbente de agua.
ES2107196T3 (es) Metodo para desinfectar agua, tal como agua de desague en horticultura y aparato que se usa para ello.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
GT200000222A (es) Forma de dosificacion de farmacos accionada por un hidrogel.
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
DK1418951T3 (da) Transdermalt teraeutisk system (TTS) med fentanyl som aktiv bestanddel
NO20050060L (no) Medikament for behandling av overaktiv blaere
AR032151A1 (es) Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
BRPI0409681A (pt) derivados de wortmanina solúveis em água
ATE265998T1 (de) Propancarbonsäure-amidoxim derivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese entahlten
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
ATE253940T1 (de) Stabile lösung von calcitriol zum verpacken in phiolen
MX9704490A (es) Tratamiento terapeutico combinado de las patologias hiperproliferativas.
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
ATE295165T1 (de) Mittel zur adjuvanten therapie von demenzen enthaltend alpha-liponsäure
ES2109561T3 (es) Procedimiento para la depuracion de aguas destinadas al consumo humano.
ES2163528T3 (es) Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina.

Legal Events

Date Code Title Description
FG Grant, registration